psalexa
P&S Market Research - A market research firm

Arterial Stiffness Therapeutics Pipeline Analysis

Arterial Stiffness Therapeutics Pipeline Analysis 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

Delivery : 1-2 Working Days
Report Code: LS11209
Available Format:

Arterial stiffness is a type of cardiovascular disorder that occurs due to arteriosclerosis and aging. Stiffness can be defined as the viscoelastic property that anticipate the relationship between change in volume and change in pressure. Due to decrease in capacity of reservoir and recoiling elasticity, the diastolic pressure decreases and pulse pressure increases. Lower diastolic pressure can increase the risk of renal impairment and stroke. However, it also reduces coronary artery perfusion leading to subendocardial ischemia. Arterial stiffness can be diagnosed by doppler analysis. Omeros Corporation is in the process of developing GPR25 as a G protein-coupled receptor agonist for the treatment of arterial stiffness. NattoPharma ASA is in the process of developing menaquinone-7 for the treatment of arterial stiffness. Some of the companies having the pipeline of arterial stiffness include Omeros Corporation, NattoPharma ASA and others.

The report provides a comprehensive understanding of the pipeline activities covering all drug candidates under various stages of development, with the detailed analysis of pipeline and clinical trials. Pipeline analysis of drugs by phases includes product description and development activities including information about clinical results, designations, collaborations, licensing, grants, technology, and others.

Place An Order

Single User License
question-mark

The report will be delivered in PDF format without printing rights. It is recommended for a single user.

USD 3250
Group License
question-mark

The report will be delivered in PDF format along with the printing rights. It is recommended for up to five users.

USD 4000
Enterprise License
question-mark

The report will be delivered in PDF format along with printing rights and detailed Excel sheet. It is recommended for organizations where multiple people would like to access the report from multiple locations.

USD 7750

Pre-Purchase Enquiry